These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Naproxen-induced lichen planus: report of 55 cases.
    Author: Güneş AT, Fetil E, Ilknur T, Birgin B, Ozkan S.
    Journal: Int J Dermatol; 2006 Jun; 45(6):709-12. PubMed ID: 16796633.
    Abstract:
    BACKGROUND: Clinical and histopathological differential diagnosis is usually impossible in drug-induced lichen planus (LP) and idiopathic LP. Naproxen is a nonsteroidal anti-inflammatory drug, which is widely used for its analgesic, antipyretic and anti-inflammatory effects. To the best of our knowledge, two case reports on naproxen-induced LP have been reported. METHODS: Fifty-five patients with LP, and a history of naproxen intake before their eruption, were investigated. RESULTS: Twenty-five patients (45.5%) had a history of naproxen intake prior to their eruption without any other medication. Twelve patients (21.8%) had a history of simultaneous use of naproxen with other drugs that were reported as inducers of LP. Eighteen patients (32.7%) had given a history of using naproxen together with drugs that had not been previously reported as inducers of LP. Moreover, in 42 patients, eruptive-type LP development after naproxen intake, is an interesting observation. New lesions were not observed after the cessation of naproxen intake in any of the patients. CONCLUSION: Naproxen might be accepted as an important inducer for LP, especially for the eruptive form.
    [Abstract] [Full Text] [Related] [New Search]